INFUSYSTEM HOLDINGS, INC Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)
INFUSYSTEM HOLDINGS, INC (INFU) reported Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) of $0 for the 1-month period ending 2020-10-31, per its 10-K filed 2021-03-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill · last filed 2021-03-22
- 2020-10-31: Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 1 month $0.00.
- 2019-10-31: Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 1 month $0.00.
- 2018-10-31: Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 1 month $0.00.
- 2017-10-31: Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 1 month $0.00.
| Period end | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 1 month |
|---|---|---|
| 2020-10-31 | $0.00 10-K · filed 2021-03-22 | |
| 2019-10-31 | $0.00 10-K · filed 2020-03-30 | |
| 2018-10-31 | $0.00 10-K · filed 2019-03-22 | |
| 2017-10-31 | $0.00 10-K · filed 2018-03-19 | |
| 2016-10-31 | $0.00 10-K · filed 2017-03-22 | |
| 2015-10-31 | $0.00 10-K/A · filed 2016-12-12 | |
| 2014-10-31 | $0.00 10-K · filed 2015-03-09 | |
| 2013-10-31 | $0.00 10-K · filed 2014-03-11 | |
| 2012-10-31 | $0.00 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |